COVID-19 Treatment Candidates, at a Glance

More than a year into the pandemic, a handful of vaccines have been authorized for the novel coronavirus in the U.S., yet there is still no cure for COVID-19. Researchers and doctors have been racing to find drugs and therapies that could treat the disease or prevent people from getting infected. Only one drug, Gilead Sciences’ Veklury (remdesivir), has been approved by the FDA, while several treatments received an emergency use authorization (EUA). Here’s a look at some of the key treatments/candidates currently in play:

© 2023 MMIT
Jinghong Chen

Jinghong Chen Reporter

Jinghong produces infographics and data stories on health insurance and specialty pharmacy for AIS Health. She graduated from Missouri School of Journalism with a focus on data journalism and international reporting. Before joining AIS in 2018, she worked at WBEZ, Al Jazeera English and The New York Times Chinese.

Related Posts

doctor-speaking-to-a-patient
May 25

Commercial Insurance Restrictions Complicate Biosimilar Adoption

READ MORE
shell-game
May 25

‘Shell Game’ or Rebate Maximizers? FTC Probe Reignites Debate Over GPOs

Read More
pills-in-hand
May 25

As Weight Loss Drugs’ Star Rises, Plan Sponsors, Researchers Worry About Costs

READ MORE

GAIN THERAPEUTIC AREA-SPECIFIC INTEL TO DRIVE ACCESS FOR YOUR BRAND

Sign up for publications to get unmatched business intelligence delivered to your inbox.

subscribe today